Moolec Science SA (MLEC)
NASDAQ: MLEC
· Real-Time Price · USD
8.65
-0.37 (-4.10%)
At close: May 23, 2025, 3:54 PM
8.90
2.83%
After-hours: May 23, 2025, 04:00 PM EDT
Company Description
Moolec Science SA, a science-based ingredient company, focuses on producing animal proteins in plants through Molecular Farming, a disruptive technology in the alternative protein landscape.
The company's product portfolio and pipeline leverage the agronomic efficiency of used target crops, such as soybeans and peas.
It operates in the United States, Europe, and South America.
The company was founded in 2008 and is based in Luxembourg.
Moolec Science SA
| Country | LU |
| IPO Date | Mar 2, 2021 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 52 |
| CEO | Henk Hoogenkamp Ph.D. |
Contact Details
Address: 17 Boulevarrd F.W. Raiffeisen, Luxembourg, LU | |
| Website | https://moolecscience.com |
Stock Details
| Ticker Symbol | MLEC |
| Exchange | NASDAQ |
| Fiscal Year | July - June |
| Reporting Currency | USD |
| CIK Code | 0001937737 |
| CUSIP Number | |
| ISIN Number | LU2559000059 |
| Employer ID | 00-0000000 |
| SIC Code | 6770 |
Key Executives
| Name | Position |
|---|---|
| Jose Lopez Lecube M.B.A. | Chief Financial Officer & Executive Director |
| Catalina Jones B.A. | Chief of Staff & Sustainability |
| Dr. Amit Dhingra Ph.D. | Chief Science Officer |
| Florencia Bottero | Corporate Counsel & Secretary of the Board |
| Henk Hoogenkamp Ph.D. | Co-Founder & Chief Product Officer |
| Martin Salinas Ph.D. | Chief of Technology & Co-Founder |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| May 13, 2025 | 6-K | Filing |
| Apr 29, 2025 | 6-K | Filing |
| Apr 23, 2025 | 6-K | Filing |
| Apr 21, 2025 | 6-K | Filing |
| Apr 18, 2025 | 6-K | Filing |
| Apr 16, 2025 | 6-K | Filing |
| Apr 09, 2025 | 6-K | Filing |
| Apr 08, 2025 | 6-K | Filing |
| Apr 04, 2025 | 6-K | Filing |
| Mar 28, 2025 | 424B3 | Filing |